230 related articles for article (PubMed ID: 27411378)
21. Prognostic Value of High CXCR4 Expression in Renal Cell Carcinoma: A System Review and Meta-Analysis.
Du Y; Long Q; Guan B; Mu L
Dis Markers; 2015; 2015():568980. PubMed ID: 26526157
[TBL] [Abstract][Full Text] [Related]
22. A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
Gremel G; Djureinovic D; Niinivirta M; Laird A; Ljungqvist O; Johannesson H; Bergman J; Edqvist PH; Navani S; Khan N; Patil T; Sivertsson Å; Uhlén M; Harrison DJ; Ullenhag GJ; Stewart GD; Pontén F
BMC Cancer; 2017 Jan; 17(1):9. PubMed ID: 28052770
[TBL] [Abstract][Full Text] [Related]
23. Carbonic anhydrase IX immunohistochemistry has potential to predict renal cell carcinoma outcomes: A systematic review and meta-analyses.
Samberkar S; Rajandram R; Mun KS; Samberkar P; Danaee M; Zulkafli IS
Malays J Pathol; 2019 Dec; 41(3):233-242. PubMed ID: 31901907
[TBL] [Abstract][Full Text] [Related]
24. Circular RNAs as prognostic and diagnostic biomarkers in renal cell carcinoma.
Rashedi S; Mardani M; Rafati A; Khavandi MM; Mohammadi F; Javanshir S; Sarallah R; Dolatshahi M; Sabahi M; Azadnajafabad S; Tavolinejad H; Rezaei N
J Clin Lab Anal; 2022 Oct; 36(10):e24670. PubMed ID: 35989533
[TBL] [Abstract][Full Text] [Related]
25. Prognostic and clinicopathological significance of circulating tumor cells detected by RT-PCR in non-metastatic colorectal cancer: a meta-analysis and systematic review.
Yang C; Zou K; Zheng L; Xiong B
BMC Cancer; 2017 Nov; 17(1):725. PubMed ID: 29115932
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of survivin expression in patients with colorectal carcinoma: a meta-analysis.
Huang YJ; Qi WX; He AN; Sun YJ; Shen Z; Yao Y
Jpn J Clin Oncol; 2013 Oct; 43(10):988-95. PubMed ID: 23894202
[TBL] [Abstract][Full Text] [Related]
27. MicroRNAs as prognostic molecular signatures in renal cell carcinoma: a systematic review and meta-analysis.
Gu L; Li H; Chen L; Ma X; Gao Y; Li X; Zhang Y; Fan Y; Zhang X
Oncotarget; 2015 Oct; 6(32):32545-60. PubMed ID: 26416448
[TBL] [Abstract][Full Text] [Related]
28. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
29. Value of Ferritin Heavy Chain (FTH1) Expression in Diagnosis and Prognosis of Renal Cell Carcinoma.
Huang H; Qiu Y; Huang G; Zhou X; Zhou X; Luo W
Med Sci Monit; 2019 May; 25():3700-3715. PubMed ID: 31104064
[TBL] [Abstract][Full Text] [Related]
30. Clinicopathological significance of matrix metalloproteinase 2 protein expression in patients with renal cell carcinoma: A case-control study and meta-analysis.
Liu Q; Zhang GW; Zhu CY; Wei JX; Tian X; Li Y; Li XD
Cancer Biomark; 2016; 16(2):281-9. PubMed ID: 26756619
[TBL] [Abstract][Full Text] [Related]
31. Survivin Overexpression Is Associated with Aggressive Clinicopathological Features in Cervical Carcinoma: A Meta-Analysis.
Cheng KY; Wang ZL; Gu QY; Hao M
PLoS One; 2016; 11(10):e0165117. PubMed ID: 27764228
[TBL] [Abstract][Full Text] [Related]
32. High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.
Parker AS; Kosari F; Lohse CM; Houston Thompson R; Kwon ED; Murphy L; Riehle DL; Blute ML; Leibovich BC; Vasmatzis G; Cheville JC
Cancer; 2006 Jul; 107(1):37-45. PubMed ID: 16736510
[TBL] [Abstract][Full Text] [Related]
33. GOLPH3 is a novel marker of poor prognosis and a potential therapeutic target in human renal cell carcinoma.
Xue Y; Wu G; Liao Y; Xiao G; Ma X; Zou X; Zhang G; Xiao R; Wang X; Liu Q; Long D; Yang J; Xu H; Liu F; Liu M; Xie K; Huang R
Br J Cancer; 2014 Apr; 110(9):2250-60. PubMed ID: 24595000
[TBL] [Abstract][Full Text] [Related]
34. Cytoplasmic expression of CD133 stemness marker is associated with tumor aggressiveness in clear cell renal cell carcinoma.
Saeednejad Zanjani L; Madjd Z; Abolhasani M; Andersson Y; Rasti A; Shariftabrizi A; Asgari M
Exp Mol Pathol; 2017 Oct; 103(2):218-228. PubMed ID: 29050853
[TBL] [Abstract][Full Text] [Related]
35. Clinicopathological significance of CXCR4 expression in renal cell carcinoma: a meta-analysis.
Tang B; Tang F; Li Y; Yuan S; Li B; Wang Z; He S
Ann Surg Oncol; 2015 Mar; 22(3):1026-31. PubMed ID: 25249257
[TBL] [Abstract][Full Text] [Related]
36. Survivin expression in renal cell carcinoma.
Zamparese R; Pannone G; Santoro A; Lo Muzio L; Corsi F; Pedicillo MC; Scillitani EL; Tortorella S; Staibano S; Piscuoglio S; Lo Russo L; Bufo P
Cancer Invest; 2008 Nov; 26(9):929-35. PubMed ID: 19034775
[TBL] [Abstract][Full Text] [Related]
37. Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis.
Iacovelli R; Nolè F; Verri E; Renne G; Paglino C; Santoni M; Cossu Rocca M; Giglione P; Aurilio G; Cullurà D; Cascinu S; Porta C
Target Oncol; 2016 Apr; 11(2):143-8. PubMed ID: 26429561
[TBL] [Abstract][Full Text] [Related]
38. Significance of nm23 immunoexpression in the prognosis of renal cell carcinoma.
Filiz G; Adim S; Aytac B; Akar E; Vuruskan H
J Int Med Res; 2010; 38(2):620-4. PubMed ID: 20515575
[TBL] [Abstract][Full Text] [Related]
39. LncRNAs act as prognostic and diagnostic biomarkers in renal cell carcinoma: a systematic review and meta-analysis.
Chen J; Chen Y; Gu L; Li X; Gao Y; Lyu X; Chen L; Luo G; Wang L; Xie Y; Duan J; Peng C; Ma X
Oncotarget; 2016 Nov; 7(45):74325-74336. PubMed ID: 27527868
[TBL] [Abstract][Full Text] [Related]
40. Prognostic factors in patients with advanced renal cell carcinoma.
Muriel López C; Esteban E; Berros JP; Pardo P; Astudillo A; Izquierdo M; Crespo G; Sanmamed M; Fonseca PJ; Martínez-Camblor P
Clin Genitourin Cancer; 2012 Dec; 10(4):262-70. PubMed ID: 22959659
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
